Johnson & Johnson plans Ebola vaccine testing

SHARE Johnson & Johnson plans Ebola vaccine testing

Johnson & Johnson will begin safety testing in early January on a vaccine combination that could protect people from a strain of the deadly Ebola virus. The health care products maker said Wednesday that the vaccine being developed by its Janssen Pharmaceutical Companies protects against an Ebola strain that is “highly similar” to the virus that has triggered the current outbreak in West Africa. Johnson & Johnson also plans to test whether its vaccine protects against the version causing the outbreak, which has killed more than 4,500 people.

Read more at Newsfeed.

The Latest
The companies now plan to sell 579 Kroger and Albertsons stores in markets where they overlap to C&S Wholesale Grocers, a New Hampshire grocery supplier and operator.
A person was detained on the scene for alleged involvement, police said.
The woman struck a pole in the 3000 block of East 106th Street, police said.
Mendick, a utility infielder, has hit eight homers at Triple-A Charlotte.
For the first time since he became a NASCAR Cup team owner, Jordan was at the track to savor in person a victory by one of his drivers.